recombinant human bmp2 protein r d systems (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
recombinant human bmp2 protein r d systems
Recombinant Human Bmp2 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 218 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+bmp2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm41932341-856-64-68
Average 95 stars, based on 218 article reviews
Recombinant Human Bmp2 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 218 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+bmp2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm41932341-856-64-68
Average 95 stars, based on 218 article reviews
recombinant human bmp2 protein r d systems - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Cell Culture:Article Title: The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells Article Snippet: .. To induce osteoblastic differentiation [ ], C2C12 cells were plated in 6‐well tissue culture plates at a density of 2.0 × 10 5 cells per well and cultured in differentiation medium containing DMEM with 300 ng·mL −1 human Article Title: The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells. Article Snippet: .. To induce osteoblastic differentiation [20], C2C12 cells were plated in 6-well tissue culture plates at a density of 2.0 9 105 cells per well and cultured in differentiation medium containing DMEM with 300 ng mL 1 human Recombinant:Article Title: The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells Article Snippet: .. To induce osteoblastic differentiation [ ], C2C12 cells were plated in 6‐well tissue culture plates at a density of 2.0 × 10 5 cells per well and cultured in differentiation medium containing DMEM with 300 ng·mL −1 human Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia Article Snippet: We used RNAeasy for RNA extraction (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Article Title: The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells. Article Snippet: .. To induce osteoblastic differentiation [20], C2C12 cells were plated in 6-well tissue culture plates at a density of 2.0 9 105 cells per well and cultured in differentiation medium containing DMEM with 300 ng mL 1 human Article Title: Novel Indolyl-Benzimidazole Compounds Promote in vitro Wound Healing and Osteogenic Differentiation of Pluripotent Cells. Article Snippet: SuperSignalTM West Femto HRP Substrate solutions for chemiluminescent imaging was from Thermo Scientific (Rockford, IL, USA). .. Article Title: Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells. Article Snippet: .. To investigate the effect of EMT-inducing agents on the nc886 expression HCC827 cells were treated with either Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia. Article Snippet: We used RNAeasy for RNA extrac- tion (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Article Title: BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity. Article Snippet: .. Where indicated cells were treated with human Article Title: BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity Article Snippet: .. Where indicated cells were treated with human Functional Assay:Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia Article Snippet: We used RNAeasy for RNA extraction (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia. Article Snippet: We used RNAeasy for RNA extrac- tion (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Live Cell Imaging:Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia Article Snippet: We used RNAeasy for RNA extraction (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia. Article Snippet: We used RNAeasy for RNA extrac- tion (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Software:Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia Article Snippet: We used RNAeasy for RNA extraction (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Article Title: IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia. Article Snippet: We used RNAeasy for RNA extrac- tion (Qiagen), and Bioanalyzer for quality control (Agilent Technologies, Santa Clara, USA). .. Additional cell treatments were performed using 20 ng/ml Expressing:Article Title: Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells. Article Snippet: .. To investigate the effect of EMT-inducing agents on the nc886 expression HCC827 cells were treated with either |
![Comparative effects of BMP9 and <t>BMP2</t> on osteogenic differentiation and osteoclastogenesis in vitro. (A) Real‐time PCR analysis of key osteogenic genes (Col1, Runx2, ALP, and OCN) in MC3T3‐E1 cells treated with 8 nM of BMP2 or BMP9 for 3, 5, and 7 days. All gene‐expression levels were normalized to GAPDH. (B) Western blot analysis of osteogenic marker proteins in cell lysates harvested after 7 days of treatment with BMP2 or BMP9. GAPDH was used as the loading control. Densitometric quantification of band intensities (integrated density) normalized to GAPDH is shown below the blots and presented as relative protein expression. (C) Western blot showing dose‐dependent p‐Smad1/5/9 in MC3T3‐E1 cells exposed to varying concentrations of BMP2 or BMP9. Phosphorylation was quantified by densitometry and expressed as fold change vs. control after normalization using [(p‐Smad1/5/9)/(total Smad1/5/9)] and further normalized to GAPDH, as shown in the graph below the blots. Asterisks indicate statistical significance for pairwise comparisons between BMP2 and BMP9 at the same concentration (****, p < 0.0001), unless otherwise indicated. (D) ALP activity and representative images of ALP staining in MC3T3‐E1 cultures after 7 days of induction with BMP2 or BMP9. (E) Alizarin Red S staining illustrating mineralized nodule formation after extended culture with BMP2 or BMP9. (F) Representative TRAP‐stained images of RAW 264.7‐derived osteoclasts following treatment with RANKL (3 nM), BMP2 (8 nM), or BMP9 (8 nM) for 5 days. TRAP‐positive multinucleated osteoclasts are indicated by arrows. Scale bar, 20 μm. (G) Quantification of TRAP‐positive multinucleated cells per well. Data are presented as the mean ± SD ( n = 3 independent experiments), and p ‐values were calculated using one‐way analysis of variance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). BMP, bone morphogenetic protein; PCR, polymerase chain reaction; ALP, alkaline phosphatase; Col1, collagen type I; Runx2, runt‐related transcription factor 2; OCN, osteocalcin; GAPDH, glyceraldehyde‐3‐phosphate dehydrogenase.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4554/pmc12974554/pmc12974554__CID-28-0-g002.jpg)
